I saw this today and thought it was pretty cool:
First Epilepsy Clinical Trial Patients Implanted with Dose-delivering Prometra II Device
"The first refractory epilepsy patients have been implanted with Prometra II programmable infusion pumps for a clinical trial of the dose-delivery devices, according to the product’s developers, Flowonix Medical and Cerebral Therapeutics."
"The ability to target-deliver anti-epilepsy medication through an established infusion pump delivery could be a treatment with profoundly positive ramifications,” Ashwini Sharan, neurosurgical and neurological professor at Jefferson University, and president of the North American Neuromodulation Society, said. “This is the first time in the world this approach is being taken.”
https://epilepsynewstoday.com/2017/...l&utm_source=facebook.com&utm_campaign=buffer
First Epilepsy Clinical Trial Patients Implanted with Dose-delivering Prometra II Device
"The first refractory epilepsy patients have been implanted with Prometra II programmable infusion pumps for a clinical trial of the dose-delivery devices, according to the product’s developers, Flowonix Medical and Cerebral Therapeutics."
"The ability to target-deliver anti-epilepsy medication through an established infusion pump delivery could be a treatment with profoundly positive ramifications,” Ashwini Sharan, neurosurgical and neurological professor at Jefferson University, and president of the North American Neuromodulation Society, said. “This is the first time in the world this approach is being taken.”
https://epilepsynewstoday.com/2017/...l&utm_source=facebook.com&utm_campaign=buffer